Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    November 2018
  1. SELVAKUMAR T, Nies M, Klein Hesselink MS, Brouwers AH, et al
    Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma.
    J Nucl Med. 2018 Nov 30. pii: jnumed.118.212449. doi: 10.2967/jnumed.118.212449.
    PubMed     Text format     Abstract available


  2. ELMOKH O, Taelmann V, Radojewski P, Roelli MA, et al
    MEK inhibition induces therapeutic iodine uptake in a murine model of anaplastic thyroid cancer.
    J Nucl Med. 2018 Nov 21. pii: jnumed.118.216721. doi: 10.2967/jnumed.118.216721.
    PubMed     Text format     Abstract available


    October 2018
  3. DE ROSE F, Braeuer M, Braesch-Andersen S, Otto AM, et al
    Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.219105. doi: 10.2967/jnumed.118.219105.
    PubMed     Text format     Abstract available


  4. BIKAS A, Wu D, Bethancourt E, Orquiza M, et al
    Detection at public facilities of (131)I in patients treated for differentiated thyroid cancer: the frequency, sites, management by security agents, and recommended physician documentation for patients.
    J Nucl Med. 2018 Oct 25. pii: jnumed.118.213256. doi: 10.2967/jnumed.118.213256.
    PubMed     Text format     Abstract available


  5. BACHER R, Hohberg M, Dietlein M, Wild M, et al
    Thyroid uptake and effective half-life of radioiodine in thyroid cancer patients at radioiodine therapy and follow-up whole-body scintigraphy either in hypothyroidism or under rhTSH.
    J Nucl Med. 2018 Oct 12. pii: jnumed.118.217638. doi: 10.2967/jnumed.118.217638.
    PubMed     Text format     Abstract available


    September 2018
  6. KREISSL M, Janssen M, Nagarajah J
    Current treatment strategies in metastasized differentiated thyroid cancer.
    J Nucl Med. 2018 Sep 6. pii: jnumed.117.190819. doi: 10.2967/jnumed.117.190819.
    PubMed     Text format     Abstract available


    August 2018
  7. SCHENKE S, Seifert P, Zimny M, Winkens T, et al
    Risk stratification of thyroid nodules using Thyroid Imaging Reporting And Data System (TIRADS): The omission of thyroid scintigraphy increases the rate of falsely suspected lesions.
    J Nucl Med. 2018 Aug 10. pii: jnumed.118.211912. doi: 10.2967/jnumed.118.211912.
    PubMed     Text format     Abstract available


    June 2018
  8. PRYMA DA
    Controversies in the Use of Radioiodine in Thyroid Cancer: We Need More and Better Data.
    J Nucl Med. 2018 Jun 22. pii: jnumed.118.214197. doi: 10.2967/jnumed.118.214197.
    PubMed     Text format    


    May 2018
  9. SCHMIDT M, Gorges R, Drzezga A, Dietlein M, et al
    Radioiodine therapy in differentiated thyroid cancer - a matter of controversy - PRO Radioiodine.
    J Nucl Med. 2018 May 10. pii: jnumed.117.191338. doi: 10.2967/jnumed.117.191338.
    PubMed     Text format     Abstract available


    April 2018
  10. TUTTLE RM
    Controversial Issues in Thyroid Cancer Management.
    J Nucl Med. 2018 Apr 13. pii: jnumed.117.192559. doi: 10.2967/jnumed.117.192559.
    PubMed     Text format     Abstract available


  11. TULCHINSKY M, Binse I, Campenni A, Dizdarevic S, et al
    Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.211359. doi: 10.2967/jnumed.118.211359.
    PubMed     Text format    


    March 2018
  12. SPANU A, Nuvoli S, Gelo I, Mele L, et al
    The role of diagnostic (131)I-SPECT/TC in patients with papillary thyroid microcarcinoma in long-term follow-up.
    J Nucl Med. 2018 Mar 1. pii: jnumed.117.204636. doi: 10.2967/jnumed.117.204636.
    PubMed     Text format     Abstract available


    December 2017
  13. TESSELAAR MH, Crezee T, Schuurmans I, Gerrits D, et al
    Digitalis-like compounds restore hNIS expression and iodide uptake capacity in anaplastic thyroid cancer.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.200675. doi: 10.2967/jnumed.117.200675.
    PubMed     Text format     Abstract available


    October 2017
  14. VASSAUX G, Zwarthoed C, Signetti L, Guglielmi J, et al
    Iodinated contrast agents perturb iodide uptake by the thyroid independently of free iodide.
    J Nucl Med. 2017 Oct 19. pii: jnumed.117.195685. doi: 10.2967/jnumed.117.195685.
    PubMed     Text format     Abstract available


  15. PATTISON DA, Bozin M, Gorelik A, Hofman MS, et al
    18F-fluorodeoxyglycose-avid thyroid incidentalomas: the importance of contextual interpretation.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.198085. doi: 10.2967/jnumed.117.198085.
    PubMed     Text format     Abstract available


  16. WERNER RA, Schmid JS, Higuchi T, Javadi MS, et al
    Predictive value of FDG-PET in patients with advanced medullary thyroid carcinoma treated with vandetanib.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.199778. doi: 10.2967/jnumed.117.199778.
    PubMed     Text format     Abstract available


    April 2017
  17. DEANDREIS D, Schlumberger M, Tuttle RM
    Reply: Fixed 100 mCi I-131 Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193185. doi: 10.2967/jnumed.117.193185.
    PubMed     Text format    


  18. NICHOLS KJ, Robeson W, Yoshida-Hay M, Zanzonico PB, et al
    Alternative Means of Estimating 131I Maximum Permissible Activity to Treat Thyroid Cancer.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.192278. doi: 10.2967/jnumed.117.192278.
    PubMed     Text format     Abstract available


  19. O' DOHERTY J, Jauregui-Osoro M, Brothwood T, Szyszko T, et al
    18F-tetrafluoroborate (18F-TFB), a PET probe for imaging sodium-iodide symporter expression: Whole-body biodistribution, safety and radiation dosimetry in thyroid cancer patients.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192252. doi: 10.2967/jnumed.117.192252.
    PubMed     Text format     Abstract available


  20. JENTZEN W, Nahum AE, Bockisch A, Binse I, et al
    Fixed 100 mCi I-131 Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192872. doi: 10.2967/jnumed.117.192872.
    PubMed     Text format    


    March 2017
  21. KIM EE
    Thyroid Cancer: A Comprehensive Guide to Clinical Management; Third Edition.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.193177. doi: 10.2967/jnumed.117.193177.
    PubMed     Text format    


    February 2017
  22. VAN NOSTRAND D
    Prescribed activities of I-131 therapies in differentiated thyroid cancer: Invited Commentary.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.188862. doi: 10.2967/jnumed.116.188862.
    PubMed     Text format    


  23. SOLNES LB, Jones KM, Rowe SP, Pattanayak P, et al
    Diagnostic Value of 18F-FDG PET/CT versus MRI in the Setting of Antibody Specific Autoimmune Encephalitis.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.184333. doi: 10.2967/jnumed.116.184333.
    PubMed     Text format     Abstract available


  24. FLUX GD, Verburg FA, Chiesa C, Bardies M, et al
    Comparison of empiric versus whole body/blood clearance dosimetry-based approach to radioactive iodine treatment in patients with metastases from differentiated thyroid cancer.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.186643. doi: 10.2967/jnumed.116.186643.
    PubMed     Text format    


    January 2017
  25. PLYKU D, Hobbs RF, Huang K, Atkins F, et al
    Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.179366. doi: 10.2967/jnumed.116.179366.
    PubMed     Text format     Abstract available


    October 2016
  26. LANGEN B, Rudqvist N, Helou K, Forssell-Aronsson EB, et al
    Microarray Studies on 211At Administration in BALB/c Nude Mice Indicate Systemic Effects on Transcriptional Regulation in Non-Thyroid Tissues.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.176958.
    PubMed     Text format     Abstract available


  27. DEANDREIS D, Rubino C, Tala H, Leboulleux S, et al
    Comparison Of Empiric Versus Whole Body/Blood Clearance Dosimetry-Based Approach To Radioactive Iodine Treatment In Patients With Metastases From Differentiated Thyroid Cancer.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.179606.
    PubMed     Text format     Abstract available


  28. SELIVANOVA S, Lavallee E, Senta H, Caouette L, et al
    Clinical Trial Using Sodium Pertechnetate 99mTc Produced with Medium-Energy Cyclotron: Biodistribution and Safety Assessment in Patients with Abnormal Thyroid Function.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.178509.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: